Kidney protective mechanisms of SGLT2 inhibitors: evidence for a hemodynamic effect.

Yau, Kevin; Cherney, David Z I; van Raalte, Daniël H; Wever, Britt E

Yau, Kevin; Cherney, David Z I; van Raalte, Daniël H; Wever, Britt E.

Affiliation

Yau K; Division of Nephrology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Cherney DZI; Division of Nephrology, Department of Medicine, University Health Network, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address: david.cherney@uhn.ca.
van Raalte DH; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Research Institute Amsterdam Cardiovascular Sciences, Vrije Universiteit University, Amsterdam, the Netherlands; Department of Vascular Medicine, Amsterdam University Medical Centers,
Wever BE; Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Research Institute Amsterdam Cardiovascular Sciences, Vrije Universiteit University, Amsterdam, the Netherlands.

Kidney Int ; 105(6): 1168-1172, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38777402

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sodium-Glucose Transporter 2 Inhibitors / Hemodynamics / Kidney Limits: Animals / Humans Language: En Journal: Kidney Int / Kidney int / Kidney international Year: 2024 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google